ArticleAdvanced healthcare materials2026
Synergistic Immunomodulation and Angiogenesis-Driven Microenvironment Remodeling via Bioactive Hydrogel/Nanofiber Composites for Enhanced Infectious Wound Healing.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Numerous types of wounds are at risk for infection, such as burn wounds, traumatic wounds, surgical wounds, chronic ulcer wounds, and radiologic wounds. The repair of infectious wounds depends on specific microenvironments, including moderate hydration, reactive oxygen scavenging, antimicrobial, anti-inflammatory, and angiogenic conditions. To effectively promote the repair of infectious wounds and reduce the risk of infection spread, we developed a multifunctional bilayer wound dressing (MBWD) that simultaneously meets these criteria. The inner layer (DMOG@PCL/ASC) consists of a polycaprolactone (PCL)/fish collagen (ASC) nanofiber decorated with coaxial microparticles containing dimethyloxalylgcine (DMOG). The three-dimensional pore structure of nanofibers offers numerous adhesion sites for cells, and the gradual release of DMOG can promote angiogenesis. The outer layer consists of a glycidyl methacrylate-modified carboxymethyl chitosan hydrogel loaded with cerium oxide nanozymes (M-CMCS/CeO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.